Trials / Completed
CompletedNCT00747500
Non Interventional Post Marketing Programme in Acromegaly
An Observational, Multicentre, Open Label, Non Interventional Programme to Assess the Long-term Safety and Efficacy of Somatuline® Autogel® in the Treatment of Acromegaly When Administered by Patients or Their Partners ("Home Injection Group") or Administered by Healthcare Professionals.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 42 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study, is to assess the safety and local tolerability of the long-term use of Somatuline Autogel when administered by patients or their partners ("Home Injection Group") and the safety and local tolerability in patients receiving their injection from a healthcare professional (HCP) ("Reference Group").
Conditions
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2012-09-01
- Completion
- 2013-03-01
- First posted
- 2008-09-05
- Last updated
- 2019-01-07
Locations
7 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00747500. Inclusion in this directory is not an endorsement.